Crowdfunding Meets Biotech Financing – will it end in tears?

A growing number of people are looking at crowdfunding as a source of funding for biotech financing. It might seem surprising given that biotech financing is a high risk multimillion dollar bet, however this has not stopped several crowdfunding start-ups appearing on the block. Crowdfunding is the process whereby individuals club together to provide collective funds for a project or …

Download: Asia’s most promising biotechs & their pipelines [Part II]

The Asia-Pacific's growing and maturing biopharmaceutical industry offers tremendous business and investment opportunities. China, India, Australia, Taiwan South Korea and Japan have already established themselves as serious players, committing significant amounts to investment in the next five to ten years to strengthen their capabilities. The level of mergers and acquisitions (M&A) is expected to pick up and investors can expect …

eBook: Asian Biotech CEOs reveal industry trends, opportunities and challenges

Biotechnology is one of the most important emerging technologies of the 21st century and has already attracted worldwide interest. Although Asian biotech industry is still years away from reaching the status the industry has elsewhere, it has matured significantly in the past 10 years and been recognized as a hotspot for biotech development. Click here to download this eBook We …

Download Ebook: Top 20 Big Data projects in Pharma & Biotech

The promise of big data Every patient experience generates a massive amount of data which, when pooled together, can give a detailed account of their health, the effectiveness & safety of the drugs they are taking and when aggregated from other patient's data a vast library of information about entire disease states and clinical populations. Understandably pharma is now armouring …

Managed Entry Trumps Risk Sharing

Mr Ed Schoonveld, Managing Principal, Market Access & Pricing Leader, Author of ‘The Price of Global Health’, ZS Associates Inc   Managed Entry Agreements (MEAs) moves beyond sharing risk to targeted solutions that address evidence gaps and financial constraints Since 2000, pharmaceutical and biotech companies have engaged in agreements with government and private payers across the world to gain market …

What a “surprise”, Neostem is hot!

On a recent release by Aegis Capital the NY-based biotech Neostem has been upgraded to a buy rating and a $2.5 price target. The company which has been undervalued in the cell therapy industry, has four promising platforms, including its leading candidate AMR-001 for repair of heart muscle function following an acute myocardial infarction. Most of the company's upgraded rating …

Ebook: Top 20 Big Data projects in Pharma & Biotech – Part 2

    There are 5 main areas of Big Data investigation in real world outcomes by pharma today… Remote, mobile health – The use of mobile devices such as smart phones to gather data on treatment adherence, on-going patient care, predictive symptoms or adverse events and health outcomes Healthcare provider data – Collecting data from electronic medical records that includes …

Stem cell therapy wins the battle again

The battle to successfully develop stem cell therapies has been long and difficult for scientists and researchers. However, with tenacity and relentless efforts, there have been significant breakthroughs which led the industry forward. It has provided hope for patients with fatal conditions who have no other alternative. One of the recent advancements was in Boston. Two men with HIV that …

eBook: Asia’s 20 most promising biotechs and their pipelines

The Asia-Pacific's growing and maturing sector of biopharmaceutical industry offers tremendous business and investment opportunities. China, India, Australia, Taiwan South Korea and Japan have already established themselves as serious players, committing significant amounts to investment in the next five to ten years to strengthen their capabilities. The level of mergers and acquisitions (M&A) is expected to pick up and the …